This project evaluated the implementation and costs of precision medicine through the Zero Childhood Cancer Program (ZERO). The work has demonstrated the cost-effectiveness of a precision medicine program as a new model of care. It has also provided insights into the barriers and facilitators in delivering a precision medicine program of this scale. The health economics and implementation science approaches used were pioneering in the context of pediatric cancer precision medicine in Australia.

Collaborations

• Children’s Cancer Institute (Australia)
• Kids Cancer Centre, Sydney Children’s Hospital, Randwick (Australia)
• The Children’s Hospital Westmead (Australia)
• Zero Childhood Cancer national and international partners network (8 hospitals, 20 research institutes), incl. all three NSW Paediatric oncology centres, Children’s Hospital Westmead, Sydney Children’s Hospitals Network, John Hunter Children’s Hospital, and Sydney Children’s Hospital, Randwick (Australia)
• School of Women’s and Children’s Health, University of New South Wales (Australia)
• Australian Institute for Health and Innovation, Macquarie University (Australia)
• GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University (Australia)